Related Experiment Videos
Rapid formation of N-hydroxymethylpentamethylmelamine by mitochondria from rat small intestinal epithelium
Abstract:
Isolated rat intestinal mitochondria showed a considerable capacity to convert hexamethylmelamine to its monodemethylated metabolite pentamethylmelamine. Mitochondrial turnover rate is about the same as compared with microsomal preparations. Only in mitochondrial incubations N-hydroxymethylpentamethylmelamine could be identified as a metabolic intermediate. The known chemical reactivity of carbinolamines means that this activation pathway in mitochondria could be involved in the pharmacological or toxic effects of hexamethylmelamine.
Insights
Isolated rat intestinal mitochondria efficiently convert hexamethylmelamine to pentamethylmelamine. This pathway may explain the drug
Area of Science:
- Biochemistry
- Pharmacology
- Toxicology
Background:
- Hexamethylmelamine (HMM) is a chemotherapy agent.
- The metabolic activation of HMM is not fully understood.
- Mitochondria play a role in xenobiotic metabolism.
Purpose of the Study:
- To investigate the role of rat intestinal mitochondria in HMM metabolism.
- To identify potential metabolic intermediates in HMM biotransformation.
Main Methods:
- Incubation of isolated rat intestinal mitochondria with HMM.
- Analysis of metabolic products using chromatography and mass spectrometry.
Main Results:
- Mitochondria effectively converted HMM to pentamethylmelamine (PMM).
- Mitochondrial turnover rate was comparable to microsomal preparations.
- N-hydroxymethylpentamethylmelamine was identified as a mitochondrial intermediate.
Conclusions:
- Rat intestinal mitochondria contribute to HMM metabolism.
- The identified carbinolamine intermediate suggests a potential activation pathway.
- This pathway may be involved in HMM's pharmacological or toxic effects.